Etiological study of urinary bladder carcinoma in patients presenting to tertiary care centre
DOI:
https://doi.org/10.18203/2349-2902.isj20205664Keywords:
Carcinoma bladder, Etiology, Non-smokerAbstract
Background: Urothelial carcinoma is the most common invasive cancer of the urinary tract. Lately, there has been an increased incidence of urothelial neoplasia due to exposure to a wide range of potentially carcinogenic substances. Studies of involved factors led to the concept of existence of a so-called malignization terrain, which claims that individual genetic predisposition and chronic exposure to carcinogens act synergistically leading to the appearance of urothelial carcinomas of the bladder. Aim of the research was to find out the common etiological factors of bladder cancer in this part of India.
Methods: The study included 100 patients of bladder carcinoma reporting to Sri Guru Ram Das Hospital, Amritsar from March 2018 to December 2019. A detailed history was taken to have the insight of various etiological factors of the disease. The data was entered in Microsoft excel spreadsheet and analysis was done using statistical package for social sciences (SPSS) version 21.0.
Results: The most common blood group associated with CA UB was A +ve (39%) followed by B +ve (29%). 89% of the cases of CA UB were non-smokers predominantly attributed to type of patients coming to our tertiary care institute which are from a rural background (73%) and are mostly Sikhs (80%) and Sikhs are traditionally non-smokers. 80% were farmers by occupation who have exposure to pesticides, insecticides, weedicides and herbicides routinely.
Conclusion: In our study majority of the patients turned out to be non-smokers and A +ve blood group in contrast to the strong predilection of smoking and bladder cancer.
References
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents Vol VIII. IARC Scientific publication No 155.
National Cancer Registry Program. Consolidated report of population based cancer registries. 2006.
Morrison AS. Advances in the etiology of urothelial cancer. Urol Clin North Am. 1984;11:557-66.
Le Pendu J, Marionneau S, Cailleau T, Rocher J, Moullac-vaidye B, Clement M. ABH and Lewis histo-blood group antigens in cancer. APMIS. 2001;109:9-31.
Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6A):434.
Biswas RR, Mangal S, Guha D, Basu K, Karmakar D. An epidemiological study of cases of urothelial carcinoma of urinary bladder in a tertiary care centre. J Krishna Institute of Med Sci Univ. 2013;2:82-8.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):359-86.
Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6A):434.
Schairer C, Hartge P, Hoover RN, Silverman DT. Racial differences in bladder cancer risk a case-control study. Am J Epidemiol. 1988;128(5):1027-37.
Marcus PM, Hayes RB, Vineis P, GarciaClosas M, Caporaso NE, Autrup H, et al. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev. 2000;9(5):4617.
Kiemeney LA, Schoenberg M. Familial transitional cell carcinoma. J Urol. 1996;156(3):867-72.
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic populationbased assessment of cancer risk in first degree relatives of cancer probands. J Natl Cancer Inst. 1994;86(21):160-8.
Vineis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch Environ Health. 1991;46(1):615.
Markowitz SB, Levin K. Continued epidemic of bladder cancer in workers exposed to ortho-toluidine in a chemical factory. J Occup Environ Med. 2004;46(2):154-60.
Koutros S, Silverman DT, Alavanja MC, Andreotti G, Lerro CC, Heltshe S, et al. Occupational exposure to pesticides and bladder cancer risk. Int J Epidemiol. 2015;45(3):792-805.
Sharma T, Jain S, Verma A, Sharma N, Gupta S, Arora VK, Dev Banerjee B. Gene environment interaction in urinary bladder cancer with special reference to organochlorine pesticide: a case control study. Cancer Biomarkers. 2013;13(4):243-51.
Wesseling C, Antich D, Hogstedt C, Rodríguez AC, Ahlbom A. Geographical differences of cancer incidence in Costa Rica in relation to environmental and occupational pesticide exposure. Int J Epidemiol. 1999;28(3):365-74.
Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF. Urinary tract infection and risk of bladder cancer. Am J Epidemiol. 1984;119(4):510-5.
Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta. 1999;1473:247-66.
Orlow I, Lacombe L, Pellicer I, Rabbani F, Delgado R, Zhang ZF, et al. Genotypic and phenotypic characterization of the histoblood group ABO (H) in primary bladder tumors. Int J Cancer. 1998;75(6):819-24.
Chihara Y, Sugano K, Kobayashi A, Kanai Y, Yamamoto H, Nakazono M, et al. Loss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO gene. Lab Investig. 2005;85(7):895.
Primdahl H, Von der Maase H, Sørensen F, Wolf H, Ørntoft T. Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer. J Cancer Res Clin Oncol. 2002;128(6):295-301.
Caygill CP, Royston C, Charlett A, Wall CM, Gatenby PA, Ramus JR, et al. Barrett’s, blood groups and progression to oesophageal cancer: is nitric oxide the link? Eur J Gastroenterol Hepatol. 2011;23(9):801-6.
